CA-125 Blood Test: Normal range & Its Role as an Ovarian Cancer Test скачать в хорошем качестве

CA-125 Blood Test: Normal range & Its Role as an Ovarian Cancer Test

#CA125#Ovariancancer Disclaimer: IYBT is not a substitute for your Doctor consultation. Blood work only acts as a supportive workup to your physical examination and always needs to correlated by a professional doctor before taking any step in the management. Hence, seeking the advice of a professional doctor in the related field is adviced for questions related to you symptoms , diagnosis and management. If you have or suspect that you have a medical problem or condition, please contact a qualified health care professional immediately. You should never disregard or post pone the medical advice given by your doctor just because you have seen or read the content in the channel Full form of CA 125 is Cancer Antigen 125.It is a tumor marker for ovarian cancer. Normal levels are less than 35 U/L. Increased levels are seen in ovarian cancer. CA 125 is a mucinous protein present on the epithelial surfaces of the eye, respiratory tract, ovaries CA 125 is specifically seen increased in epithelial cell cancers. More over it has higher chances of being positive only in advanced stages of cancer .It is NOT USED for screening of ovarian cancer as it is not sensitive and specific. It needs to correlated clinically and always should be correlated with other diagnostic tests. Role in Endometriosis: It is not a sensitive marker for endometriosis. Levels are greater than 35 are especially seen in stage 3&4 of endometriosis. Levels greater than 100 U/mL indicate extensive pelvic adhesion's. However the most accurate test for diagnosis of endometriosis is Laproscopy(Direct Visualisation). NEW MARKER HE4 - Human Epididymis Protein 4 (HE4) is a relatively new marker for Ovarian malignancy and indicates gene over expression. It is used to monitor recurrence & disease progression in patients with Epithelial ovarian malignancy. HE4 when used in conjunction with CA 125 helps in estimating the Risk Of Ovarian Malignancy (ROMA) in premenopausal / postmenopausal females presenting with an adnexal mass. More info : https://www.interpretyourbloodtests.com www.facebook.com/interpretyourbloodtests/ Music from www.bensound.com